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Purpose: There is experimental evidence that self-expandable endoprostheses are appropriate for compensation of aortic
growth. A potential future application includes their use in the treatment of aortic coarctation. Yet their behavior is
poorly investigated. The present study evaluates the performance of largely oversized self-expandable endoprostheses
(EPs) in the growing porcine aorta and the biologic response toward them.
Methods: Twenty oversized EPs (Talent, TalentLoPro, Stenway, and Wallstent; nominal lumen area 314 mm2 [diameter
20 mm]) were implanted in the descending thoracic aorta of juvenile pigs. Four nonoversized EPs (TalentLoPro; nominal
lumen area 154 mm2 [diameter 14 mm]) served as controls. Cross sections of aorta and EPs were measured by
intravascular ultrasound (IVUS) at implantation and 3 months follow-up. The histologic response was assessed by
microscopy.
Results: At implantation, the EPs were 99  41% oversized relative to the aortic area [48  22% in diameter]. At
follow-up, the area of the aortic lumen increased 60  50%, P < .001 [29  23% in diameter]. The Stenway EPs
demonstrated the largest prosthetic lumen with 80  10% of their nominal area (P  .001). However, the prosthetic
lumen area was reduced by intimal hyperplasia in all devices. The largest perfused lumen was obtained by the TalentLoPro
EPs due to their progressive expansion. Nonoversized EPs resulted in a significantly smaller perfused lumen (P  .012).
The inflammatory response to polyester was moderate, whereas polyurethane evoked an extensive body-foreign reaction.
Conclusion: Large oversizing of self-expandable EPs is essential in order to maintain a large perfused lumen during aortic
growth, thereby minimizing the adverse effect of intimal hyperplasia. This was best achieved by the TalentLoPro EPs. (J
Vasc Surg 2003;38:1368-75.)
Self-expandable stents remain attached to the aortic
wall during the phase of growth, whereas rigid stents par-
tially lose contact to the underlying vessel due to their fixed
initial dimensions.1 The problematic relationship between
intraluminal device and growing aorta is relevant in the
endovascular treatment of coarctation of the juvenile aorta
(CoA), and it is investigated on experimental and clinical
bases.2-10 Preferential use is given to balloon-expandable
stents with high radial force preventing recoil of the dis-
eased aortic segment after dilation. Secondary to growth of
the aorta, stent redilation at the level of CoA is sometimes
required because of a stenosis.6,9,11 Careful imaging studies
revealed partial detachment of the stent ends from the
enlarging aortic wall beyond the level of CoA; yet, conse-
quences such as thrombosis or embolization were not
observed.11,12
Endoprostheses (EPs) consisting of a metallic frame
and a fabric covering are constantly evolving and may
provide new perspectives for endovascular CoA treatment,
enabling more assertive dilation through the implanted EP
without risk of aortic rupture or pseudoaneurysm forma-
tion.11 Oversizing of self-expandable EPs probably allows
for compensation of growth without separation from the
aortic wall. At follow-up, an eventual restenosis at the level
of the CoA could be securely redilated thanks to the endo-
prosthetic covering, which seals an aortic tear immediately.
The interaction between oversized EPs and a growing aorta
is poorly investigated. Most of the experimental studies
have focused on the performance of rigid, balloon-expand-
able stents in the context of CoA and the feasibility of
redilation at termination of growth.2-5 A single study only
has addressed the performance of oversized, self-expand-
able Gianturco stents in an enlarging aorta.1 So far, no data
are available for investigating the response of a growing
aorta toward oversized EPs with a covering.
A shortcoming of the previously mentioned studies is
the use of the diameter instead of the cross-sectional area to
demonstrate enlargement of the devices. The cross-sec-
tional area is the crucial parameter for analysis of the lumen
for two reasons: First, the prosthetic lumen of a recently
implanted EP can be considerably irregular, and therefore,
it is impossible to define the representative diameter. Sec-
ond, area times velocity defines the blood flow in a linear
approximation, and therefore, the area (not the diameter)
determines the hemodynamic significance. This study eval-
uates the performance of different types of oversized cov-
ered EPs in a normal juvenile porcine aorta by analyzing the
lumen area over time, and it assesses the healing response of
the underlying vessel.
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METHODS
Endoprostheses. Four different types of oversized,
self-expandable EPs were evaluated. Manufacturers indi-
cated a standard nominal diameter of 20 mm and a length
varying from 40 to 60 mm when the EPs are fully expanded
ex vivo. We calculated their nominal area as 314 mm2,
using the formula arear2. Four EPs of each type were
implanted. They were supplied sterile and by courtesy of
the manufacturers (Talent: World Medical Manufacturing
Corp, Sunrise, Fla; Stenway: Stenford Groupe Valendons
S.A., Nanterre, France; Wallstent: Schneider Europe AG,
Bu¨lach, Switzerland). The four types of EPs were as fol-
lows:
● Talent EPs made of three monofilament (.55-mm) niti-
nol serpentines in series connected with a single mono-
filament. The outer covering was a fabric of woven,
low-permeability polyester (.18 mm). The total length
was 50 mm, including the zigzag-shaped open web that
had no fabric between the triangles. The EPs were
mounted on a 20F delivery catheter with a central bal-
loon, and they were constrained by a retractable sheath.
● TalentLoPro EPs contained the same metallic frame as
previously mentioned, and yet the covering was made of
ultra-thin (.06 mm), ultra-high-strength woven polyes-
ter. The low profile allowed for an 18F delivery system.
● Stenway EPs consisted of thin (.45-mm) and small niti-
nol serpentines connected in series by 6-0 polypropylene
sutures, with a total device length of 40 mm. The outer
covering was woven, ultra-thin polyester (.05 mm). The
EPs were constrained by a retractable sheath on a 20F
delivery catheter with a tip balloon.
● Esophageal Wallstent EPs consisted of stainless steel
wires (.12 mm) woven in a tubular fashion with a length
of 50 mm. The frame was covered by ultra-thin sealing
polyurethane. The EPs were mounted on an 18F
Telestep Delivery System.
The nonoversized EPs were TalentLoPro devices with
a nominal area of 154 mm2 (diameter 14 mm) and a length
of 60 mm.
Implantation and evaluation by IVUS. Experimen-
tal procedures conformed to the Revised Guide for the Care
and Use of Laboratory Animals,13 and they were approved
by the institutional animal use and care committee. Twenty
EPs were implanted in the descending thoracic aorta of 20
juvenile pigs. Animals were premedicated with xylazine (.1
mg/kg) and atropine 2 mg intramuscularly (IM), and they
underwent induction of anesthesia with halothane and
oxygen. They were maintained under general endotracheal
anesthesia with a mixture of oxygen and halothane (0.5% to
1.5%) and were placed in a slightly right-lateral position.
Fig 1. Schematic drawing of the descending thoracic aorta containing an EP. The three representative cross sections
(in millimeters squared) are shown measured at different times. A, Aorta; EP, endoprosthesis; IH, intimal hyperplasia.
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They were given 2400000 IU penicillin IM. The left
thoracoabdominal side was sterilely draped. Cardiac rate
and rhythm and transcutaneous oxygen saturation were
monitored throughout the procedure.
The infrarenal aorta was exposed through a left retro-
peritoneal approach. A 9F introducer was placed in the
aorta after administration of heparin (100 U/kg intrave-
nously). In order to measure the area of the descending
thoracic aorta and the EP, intravascular ultrasound (IVUS)
with a 12.5-MHz probe (Sonicath Ultra 6; Boston Scien-
tific Corp, Watertown, Mass) and a motorized pullback
(Clear View Ultra; Boston Scientific Corp.) was performed
to measure the cross-sectional area of the aorta (aortic
lumen) and the implanted EP. The latter had a prosthetic
lumen defined by the area within the prosthesis and a
perfused lumen given by the area perfused by the blood
stream. We focused exclusively on the area and not on the
diameter for the reasons previously mentioned. Mean di-
ameters are selectively indicated in brackets to give an idea
for comparison with the literature, and we are fully con-
scious that the area, although the correct parameter, is an
unusual dimension for clinicians. We defined the proximal
landing zone 10 cm distal to the left subclavian artery
irrespective of intercostal arteries, which are here of minor
relevance for the spinal perfusion. The descending thoracic
aorta was measured by IVUS at several levels. The proximal
landing zone was identified by IVUS and fluoroscopy. The
EP was inserted over a 0.038-in guide wire through a small
aortotomy and deployed under fluoroscopy. A balloon was
used to open the self-expandable EP when it was included
in the introducer system. The EP and the aorta were
visualized by IVUS with motorized pullback, and measure-
ments of representative cross sections were taken. The area
of the aorta 5 cm from the proximal and distal end of the
implanted EP was determined in order to obtain valuable
data of aortic growth. After closure of the wound, all
animals were given 500-mg paracetamol IM every 4 to 6
hours for postoperative analgesia and 100-mg aspirin daily
thereafter .
The data acquired by IVUS were analyzed by imaging
software (EchoQuant V. 3.36; INDEC Systems, Inc, Mt
View, Calif). The area of three representative cross sections,
namely, the midportion of the EP, and the aorta were
measured (Fig 1). An eventual stenosis within the EP was
related to the proximal aorta in order to normalize for the
differences in aortic size, and it was calculated by using the
formula % stenosis  [1  (perfused lumen/aortic lumen]
 100.
Follow-up catheterization and histologic examina-
tion. At follow-up, the aorta was catheterized in a manner
similar to the method described for the implantation pro-
cedure. The cross-sectional area was measured by IVUS as
previously mentioned. After a follow-up period of 117 
18 days, the animals were euthanized, the thoracic aorta
excised, and perfusion fixated under 100-mm Hg pressure
with 10% buffered glutaraldehyde. The excised aortic spec-
imen was cut longitudinally into two halves, and the lumi-
nal surface was photographed. The specimens were pro-
cessed by dehydration and then defatted and embedded in
methyl methacrylate at 4°C. After tempering, the blocks
were cut with a diamond circular saw (EXAKT 300CP,
Norderstedt, Germany). Sections with a thickness of 500
m were taken of the representative levels. They were glued
on plexiglass and polished to a final thickness of 5 to 8 m.
Fig 2. The change of the lumen over time is shown for each type of EP, including the nonoversized EPs before and at
implantation and at follow-up.
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Two slides per level were prepared and stained with Giemsa
(G) and Van Gieson-elastin (VE) for light microscopic
examination. G was used to evaluate the cell morphology
and the inflammatory response. Inflammation was assessed
semiquantitatively as absent, minimal (one to three nodular
infiltrates), moderate (three to six infiltrates), and extensive
(more than six infiltrates per visual field at 40
magnification).
Statistical analysis. All data are presented as mean 
SD. Comparisons within one type of EP and between the
TalentLoPro EPs and the nonoversized EPs used the two-
tailed t test. Probability values of 	.05 were considered
significant.
RESULTS
Implantation and deployment at the target site were
successfully performed in each animal. Two animals devel-
oped an abscess, and one animal developed a lymphocele at
the incision site. They were successfully treated by debride-
ment and antibiotics. Mean animal weight at implantation
and autopsy was 43  11 kg and 99  16 kg, respectively.
Intravascular ultrasound scanning
The descending thoracic aorta was curved and conical.
The increase of the aortic lumen indicating growth was 60
 50% in the proximal and 77  95% in the distal thoracic
aorta (P	 .001, Fig 1). The lumen of the central part of the
EP was subjected to a changing morphology over time. At
implantation, the perfused lumen was identical with the
prosthetic lumen. At follow-up, intimal hyperplasia (IH)
rendered the luminal surface smooth, yet narrowed the
prosthetic lumen. The perfused lumen became therefore
smaller. Mean oversizing of the EPs (nominal prosthetic
area 314 mm2) related to the aortic area before implanta-
tion was 99  41% (48  22% in diameter). The nonover-
sized EPs (nominal prosthetic area 154 mm2) were mini-
mally larger than the aorta with 1%  12% (14%  9% in
diameter) in order to prevent distal dislocation.
The prosthetic lumen. At implantation, the EPs were
incompletely expanded and did not substantially dilate the
adjacent aorta. The prosthetic lumen corresponded to the
perfused lumen immediately after implantation (Fig 1).
The Wallstent and Stenway EPs achieved initially the larg-
est lumen thanks to a circumferential alignment and mini-
mal folding. In particular, the Wallstent EPs were perfectly
aligned with a smooth and circular contour. All EPs of the
type Talent showed irregular lumina with folds of the
unsupported covering. Among them the nonoversized EPs
had the smallest lumen (Figs 2 and 3 and Table I).
At follow-up, the Stenway EPs demonstrated the larg-
est prosthetic lumen with significant expansion and partially
stretched folds. The nonoversized EPs showed the smallest
prosthetic lumen as a consequence of their limited nominal
area. Thanks to their small dimensions, they achieved the
highest percentage of expansion (Table I, Fig 3).
The perfused lumen. At follow-up, the TalentLoPro
and Talent EPs had the largest perfused lumina despite
marked IH in the TalentLoPro EPs (Fig 2). The perfused
lumina of the Stenway and, in particular, of the Wallstent
EPs were smaller. Yet the smallest perfused lumina were
present in the nonoversized EPs. The comparison between
the TalentLoPro and the nonoversized EPs showed a sig-
nificantly larger prosthetic and perfused lumen at follow-up
Fig 3. IVUS imaging of the four types of EPs and the nonover-
sized EPs at implantation (1) and follow-up (2). A, Talent; B,
TalentLoPro; C, Stenway; D, Wallstent; E, nonoversized. Scale is
4.0 mm/div.
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in the oversized TalentLoPro EPs (Table II). IH narrowed
the prosthetic lumen to some extent in all of the EPs, but it
also smoothened simultaneously luminal irregularities, en-
abling an almost circular contour of the perfused lumen
(Fig 3).
Relative stenosis. An moderate stenosis of 60  14%
was present only in the Wallstent EPs (Table I).
Autopsy findings and histology
Distal spikes in 5 of the 12 Talent-like EPs penetrated
but did not perforate the aortic wall without formation of a
pseudoaneurysm. On histologic sections, the spikes pene-
trated the tunica media, but the adventitial layer remained
intact. All EPs were patent and covered by a glistening
neointima of variable thickness (Fig 4).
The Talent, TalentLoPro, and nonoversized EPs dem-
onstrated a moderate inflammation of the neointima and
interface adjacent to the covering. It consisted of nodular
and diffuse histiolymphocytic infiltrates with neovessels,
hemosiderin, and a few giant cells. The same inflammatory
pattern was present in the Stenway EPs, yet less pro-
nounced. On the contrary, the Wallstent EPs evoked a
marked foreign-body–type reaction with giant cells of the
neointima and the interface focally encroaching on the
inner media. The infiltrates were denser with numerous
giant cells. Multiple foreign bodies were present, probably
consistent with degraded polyurethane. In all of the Eps,
intimal hyperplasia developed to a different extent. It filled
out the grooves of the covering and thereby created a
circular lumen contour. The tunica media were compressed
and partially lacerated beneath the wires of the Talent,
TalentLoPro, and nonoversized EPs. Medial lesions were
less pronounced beneath the Stenway EPs and absent in the
presence of the Wallstent EPs.
DISCUSSION
Significance of oversizing and implications for fu-
ture graft design. The present study demonstrates that in
the phase of growth, oversized EPs will finally result in a
significantly larger perfused lumen than will nonoversized
EPs. Oversizing is important for two reasons. First, the
high radial force of oversized EPs probably distends the
aorta at implantation, thereby maintaining a large lumen.
On the contrary, because the expansion force of nonover-
sized EP is weaker and unable to distend the aorta, the
thickness of the endoprosthetic wall causes a marked reduc-
tion of the perfused lumen. Second, self-expandable EPs
are capable of keeping pace with aortic growth by progres-
sive expansion. Because the prosthetic lumina of oversized
EPs are initially larger than those of nonoversized EPs, a
70% to 85% increase of lumen area during growth becomes
ultimately more impressive in oversized EPs.
The design of the EP influences the area of the pros-
thetic lumen after deployment of the device. At implanta-
tion, the Wallstent EPs achieved a perfect alignment with-
out folds due to a narrow-meshed metallic frame. To the
contrary, the TalentLoPro EPs showed an irregular pros-
thetic lumen due to protruding folds of the unsupported
Table I. Expansion of the EPs and size of the perfused lumina after termination of growth
EPs
Nominal
area
(mm2)
Implantation Follow-up
Prosthetic
lumen
(mm2)
Prosthetic
lumen
(mm2)
Expansion of
prosthesis (%
nom area) P*
Perfused
lumen (mm2)
Prox aortic
lumen
(mm2)
Relative
stenosis†
(%) P‡
Talent 314 96  62 202  61 64  19 NS 162  53 232  16 31  20 0.043§
TalentLoPro 314 106  20 228  67 73  21 0.048§ 166  52 283  59 39  25 NS
Stenway 314 130  27 250  32 80  10 0.001 126  63 267  72 47  31 NS
Wallstent 314 148  33 186  39 59  13 NS 104  30 265  29 60  14 0.006
Nonoversized 154 85  4 129  13 84  8 0.012 65  21 213  90 65  19 0.053§
Prox, Proximal.
*Prosthetic lumen at implantation vs prosthetic lumen at follow-up.
†Related to the proximal aortic lumen.
‡Perfused lumen vs proximal aortic lumen.
§These values are considered not significant because of the high standard deviation.
Table II. Significance of oversizing in lumen gain during growth. Comparison between oversized and non-oversized
TalentLoPro-EPs
EPs
Implantation Follow-up
Prosthetic lumen
(mm2)
Prosthetic lumen
(mm2)
Perfused lumen
(mm2)
TalentLoPro 106  20 228  67 166  52
Nonoversized 85  4 129  13 65  21
Unpaired t test NS P  0.027 P  0.012
JOURNAL OF VASCULAR SURGERY
December 20031372 Marty et al
Fig 4. Autopsy specimen (left) and histologic cross section (right) of the four types of EPs and the nonoversized EPs.
A, Talent; B, TalentLoPro; C, Stenway; D, Wallstent; E, nonoversized. Original magnification 10.
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covering in-between the metallic zigzags. In the growing
phase, the Wallstent EPs lacked further expansion because
of their weak radial force. On the other hand, the Talent-
LoPro EPs followed aortic enlargement, thanks to their
strong expansion force. A more ideal design would prefer-
entially consist of a modified Talent-like metallic frame, yet
with closely arranged zigzags, and a covering with elastic
properties.
The larger the prosthetic lumen, the lower the effect
of IH: The rationale for oversizing. After termination of
growth, the TalentLoPro and Talent EPs showed the larg-
est perfused lumen and absence of stenosis thanks to their
wide prosthetic lumen. The impact of IH is best demon-
strated by comparing the largely oversized versus the nono-
versized EPs of the same type. IH in the TalentLoPro EPs
was irrelevant thanks to their wide prosthetic lumen. Inti-
mal thickness was comparable in the TalentLoPro and
nonoversized Eps, and therefore, it reduced the small pros-
thetic lumen of the nonoversized EPs to a much greater
extent. The Wallstent EPs, although oversized, also
showed small perfused lumina finally, which resulted in a
moderate 60% stenosis compared with the proximal aortic
lumina. We would like to reiterate that all of our data are
related to the lumen area and not to the diameter. A 75%
cross-sectional area stenosis corresponds to a 50% diameter
reduction and is considered a moderate stenosis.14 The
relative stenosis was the consequence of a combination of
minimal device expansion and IH in the Wallstent EPs.
Covering material, neointimal hyperplasia, and ves-
sel injury. The covering material consisted mainly of wo-
ven polyester well known in endovascular aneurysm exclu-
sion.15,16 The hyperplastic response toward thin woven
polyester in the present study was important in the EPs of
the TalentLoPro type. Neointimal thickness showed to be
influenced by residual folds of the covering. A neointimal
buildup smoothed folds and produced a regular luminal
contour, recreating the base for laminar flow characteris-
tics. The composition of the neointima was a moderate
foreign-body–type inflammatory reaction consistent with
findings in prosthetic graft application.17,18
The proliferative response toward polyurethane
showed a more extensive inflammation and signs of degra-
dation of polyurethane. Although the present Wallstent
EPs are specifically used for esophageal stenting in order to
occlude fistula,19 other polyurethane-covered Wallstents
have been evaluated in the vascular system.20,21 We were
interested in investigating various types of EPs in order to
obtain as much information as possible.
In the present study, the injury to the underlying aorta
consisted of a compression of the tunica media with discrete
splitting at the wire site due to the expansion force. It was
present in the EPs of the Talent type and in the Stenway
EPs, whereas it was absent in the flexible Wallstent EPs
because of their weak radial force. The penetration of some
of the distal spikes through the aortic wall, exclusively seen
in EPs of the Talent type, were probably a consequence of
the conical shape of the aorta and its curved course, con-
flicting with the cylindrical configuration of the devices.
Possible clinical applications of oversized covered
EPs. Endovascular treatment of CoA with bare stents car-
ries a risk of pseudoaneurysm formation, aortic dissection,
or disruption during dilation. Pseudoaneurysms have been
reported in the few series of CoA stenting in 6% to 17%,
namely, in six patients.7,10,12 The treatment by implanta-
tion of a second bare stent does not seem appropriate
because some aneurysms remained perfused through the
stent frame.10 Three reports in the recent literature de-
scribe successful exclusion of a pseudoaneurysm by a cov-
ered EP in the adult.7,11,22
CoA treatment by covered EPs in older children or
adults could be advantageous because of the sealing effect
of the covering, rendering intimal-medial tears innocuous.
The dilation of the CoA through the EP could be per-
formed more assertively. Oversized EPs could probably
make subsequent redilations safe up to the nominal area of
the device, and they provide proximal and distal alignment
to the aortic wall due to their progressive expansion com-
pensating for aortic growth.
In conclusion, large oversizing of self-expandable EPs
compensates for aortic growth, maintaining a large per-
fused lumen after the phase of growth. Progressive expan-
sion of the device minimizes the effect of IH. The Talent-
LoPro EPs showed the best performance. Lack of
oversizing results in a significantly smaller perfused lumen.
Today, clinical applications for covered EPs are pseudoan-
eurysms after treatment of CoA. A wider application of Eps
that are oversized and implanted in a growing organism,
seems promising, yet remains to be determined.
The authors are grateful to Mary Ellen Chatwin, PhD,
in editing this manuscript, and to Prof Claude Y. Genton,
MD, for his contribution in histology.
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